Epidemiological, diagnostic and therapeutical characterization of patients with priapism

Authors

  • Orlando Castro Maldonado Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Santiago de Cuba, Cuba.
  • Juan Enrique Meléndez Borges Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Santiago de Cuba, Cuba.
  • Isis Emérita Pedro Silva Hospital Clinicoquirúrgico Docente “Hermanos Ameijeiras”, Ciudad de la Habana, Cuba.
  • Amparo Mirabal Fariñas Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Santiago de Cuba, Cuba.
  • Alfredo Rodríguez Morales Facultad de Medicina No. 2, Santiago de Cuba, Cuba.

Keywords:

priapism, erectile sexual dysfunction, urological emergences, penis, erection.

Abstract

A descriptive and cross-sectional study of 32 patients with priapism, assisted at the Urology Service of the "Saturnino Lora Torres" Provincial Teaching Clinical Surgical Hospital in Santiago de Cuba, was carried out from January, 2008 to December, 2014, in order to characterize them from the epidemiological, diagnostic and therapeutical points of view.  The 20-29 age group and the black skin color predominated in the series, as well as and the idiopathic etiology as the most frequent one. In the 53.1% of the patients priapism type was not determined and 46.9% of them had more than 24 hours of clinical course before receiving medical assistance.  Of those who arrived between 12-24 hours only 7.1% received surgical treatment. The medical treatment was not effective in 76.5% of the patients and 54.9% of them presented erectile dysfunction.  

Downloads

Download data is not yet available.

Author Biography

Amparo Mirabal Fariñas, Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Santiago de Cuba, Cuba.

Especialista de 1er grado en urologia, Jefa de la Catedra de urologia de la Facultad No 1 de medicina, profesora asistente de urologia.

References

1. Erección persistente o priapismo. [citado 15 Dic 2014]. Disponible en: http://www.netdoctor.es/articulo/ereccion-persistente-o-priapismo

2. Rodríguez Villalba R, García S, Puigvert Martínez A, María Pomerol I Montseny J, Munárriz R. Priapismo. Actas Urol Esp. 2005 [citado 12 Nov 2014]; 29(10). Disponible en: http://scielo.isciii.es/scielo.php?pid=s0210-48062005 0010000 08&script=sci_arttext

3. Rodríguez Villalba R, García S, Puigvert Martínez A, Pomerol Montseny JM, Munárriz R. Priapismo. Actas Urol Esp. 2005 [citado 15 Dic 2014]; 29(10). Disponible en: http://scielo.isciii.es/pdf/aue/v29n10/961-968.pdf

4. Jiménez MM. El priapismo: una enfermedad de intenso dolor y potencialmente dañina. [citado 15 Dic 2014]. Disponible en:http://www.juventudrebelde.cu/ cuba/2008-07-05/el-priapismo-una-enfermedad-de-intenso-dolor-y-potencialmente-danina/

5. Broderick GA. Priapism. In: Wein AJ. Campbell-Walsh Urology. 10th ed. Philadelphia, Pa: Saunders Elsevier; 2011. p. 25.

6. Paladino N, Roldán D, Caram MS. Priapismo en pediatría: presentación inicial de una leucemia mieloide crónica. Arch argent pediatr. 2011 [citado 15 Dic 2014];109(5). Disponible en: http://www.scielo.org.ar/scielo.php? script=sci_arttext&pid=S0325-00752011000500016

7. Eland IA, Van Der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology. 2001; 57(5):970-2.

8. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res. 2001;13 suppl 5: S39-43.

9. Herreros Fernández ML, Pastor Gómez A, Gómez do Santos V, Barja Tur J, Díez García R, González Laguillo A. Priapismo: diagnóstico y tratamiento. An Pediatr. 2006;64 (5):489-91.

10. Balparda-Arias Jk. Priapismo: concepciones clínicas, diagnósticas y de tratamiento. Gaceta Médica de Bilbao. 2010 [citado 15 Dic 2014]; 107(4). Disponible en: http://www.elsevier.es/es-revista-gaceta-medica-bilbao-316-articulo-priapismo-concepciones-clinicas-diagnosticas-tratamiento-13190919

11. Priapismo. [citado 16 Ene 2015]. Disponible en: http://www.lineaysalud.com/ salud/hombres/priapismo

12. Svarch E, Hernández Ramírez P, Ballester Santovenia JM. La drepanocitosis en Cuba. Rev Cubana Hematol Inmunol Hemoter. 2004 [citado 15 Dic 2014]; 20(2). Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-02892004000 2000 09&script=sci_arttext

13. Agüero Hernández J. Priapismo. Rev Med Cos Cen. 2013 [citado 16 Ene 2015]; 70(607). Disponible en: http://www.medigraphic.com/pdfs/revmedcoscen/rmc-2013/rmc133s.pdf

14. Ibanez Suarez R, Barranco Medina J, Flores Ortiz J, Arroyo Maestre JM, Querol Canteras A. Emergencias urológicas 2: Síndrome escrotal agudo. Priapismo. [citado 16 Ene 2015]. Disponible en: http://tratado.uninet.edu/c0705i.html

15. Winter CC, McDowell G. Experience with 105 patients with priapism: update review of all aspects. J Urol. 1988; 140(5):980-3.

16. Clemente Ramos LM. Priapismo. 2010 [citado 12 Nov 2014]. Disponible en: http://www.hola.com/salud/enciclopedia-salud/2010040945137/mayores/ enfermedades-transtornos/priapismo/

17. Monkhouse SJ, Bell S. Low-flow priapism needs recognition and early correct treatment. Emerg Med J. 2007; 24(3):209-10.

18. Broseta E, Judia A, Burgues JP, Luján S, Jiménez Cruz JF. Urgencias en Urología. Priapismo. En: Urología Práctica. 3 ed. España: Editorial Ene Ediciones; 2011. p. 36-8.

19. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010; 7;(Pt2):476-500.

Downloads

Published

2015-10-12

How to Cite

1.
Castro Maldonado O, Meléndez Borges JE, Pedro Silva IE, Mirabal Fariñas A, Rodríguez Morales A. Epidemiological, diagnostic and therapeutical characterization of patients with priapism. MEDISAN [Internet]. 2015 Oct. 12 [cited 2025 Jun. 4];19(10). Available from: https://medisan.sld.cu/index.php/san/article/view/474

Issue

Vol. 19 No. 10 (2015): MEDISAN

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.